Efficacy Outcomes from RTOG 0822: A Phase II Study of Neoadjuvant IMRT with Capecitabine (c) and Oxaliplatin (o) in Patients with Locally Advanced Rectal Cancer von Hong, T.S, Moughan, J, Garofalo, M, Bendell, J, Berger, A.C, Oldenburg, N.B, Anne, P.A, Perera, F, Lee, R.J, Jabbour, S.K, Nowlan, A, DeNittis, A.S, Crane, C.H

Volltext

External Validation of the European Rectal Cancer Prognosis Model Using NRG Oncology RTOG 0822 Clinical Trial Data von Zhong, H., van Soest, J., Wang, J., Valentini, V., Geng, H., Huang, M., Cheng, C., Garofalo, M., Hong, T.S., Lerma, F.A., Keech, J., Anne, P.R., Perera, F.E., Oldenburg, N.B., Parikh, P.J., DeNittis, A.S., Zaki, B., Nowlan, A.W., Zhang, B., Dekker, A., Zhang, Z., Xiao, Y.

Volltext